Market Cap 340.35M
Revenue (ttm) 6.65M
Net Income (ttm) -136.32M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,049.92%
Debt to Equity Ratio 0.00
Volume 4,192,900
Avg Vol 4,378,518
Day's Range N/A - N/A
Shares Out 116.56M
Stochastic %K 79%
Beta 2.51
Analysts Sell
Price Target $5.41

Company Profile

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT836 which is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, FT839, to treat complex...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 875 1800
Address:
12278 Scripps Summit Drive, San Diego, United States
Rocketman808
Rocketman808 Jul. 3 at 2:33 AM
$FATE i sold my swing from 1.90 to 2.98 15k shares. Will reload if i have the chance, 285k core still here 😎
0 · Reply
MarketMaestro1
MarketMaestro1 Jul. 2 at 7:53 PM
This might be the fastest way to accumulate $1 million by the end of 2026: $DNA (Ginkgo Bioworks) → $8 Must buy $IONQ (IonQ) → $46 Must buy $EDIT (Editas Medicine) → $3.56 Must buy $FATE (Fate Therapeutics) → $3 Must buy $ADPT (Adaptive Biotechnologies) → $18 Must buy Next alert dropping soon! If you are not following us with notifications turned on, you might miss our next alerts. NFA
1 · Reply
philmori
philmori Jul. 2 at 6:50 PM
$FATE see some support... got in heavy.
0 · Reply
aquira
aquira Jul. 2 at 4:11 PM
$FATE whenever I post and brag here, this fooooken turd goes down. I'll just ignore this and wait for it to touch the 7 PT by end od year.
1 · Reply
gata2016
gata2016 Jul. 2 at 3:53 PM
$ICU We know pediatric treatment has already passed FDA. I would imagine there is a strong liklihood of adult population following suit. My low-end prediction for BO here is $125 at a modest $500M. At 1B, we are looking at a whopping $250/share. We arent far off my friends! $SLS $AUPH $FATE $CABA
2 · Reply
Merlintrader
Merlintrader Jul. 2 at 2:52 PM
$FATE Fate Therapeutics (Nasdaq: $FATE): Off-the-Shelf iPSC Cell Therapy, FT819 Lupus Data, and the Next Autoimmune CAR-T Test Updated jul 2 https://www.merlintrader.com/fate-therapeutics-stock-hub/
0 · Reply
StockDaddy68
StockDaddy68 Jul. 2 at 2:31 PM
$FATE This is what I'm buying with my profits!
1 · Reply
StockDaddy68
StockDaddy68 Jul. 2 at 2:29 PM
$FATE I just might go out and buy me a 1972 Cadillac Eldorado convertible!
1 · Reply
aquira
aquira Jul. 2 at 2:23 PM
$FATE my average of 1.365 is foooken happy
0 · Reply
gata2016
gata2016 Jul. 2 at 2:14 PM
$ICU Added about 100 more. Not a ton, but these are shares that arent going anywhere. Looking to lock the float on this one. $SLS $AUPH $FATE
0 · Reply
Latest News on FATE
Fate Therapeutics Appoints Laura Hamill to Board of Directors

Jun 15, 2026, 8:30 AM EDT - 19 days ago

Fate Therapeutics Appoints Laura Hamill to Board of Directors


Fate Therapeutics management to meet with Piper Sandler

2026-06-03T20:55:38.000Z - 4 weeks ago

Fate Therapeutics management to meet with Piper Sandler


Fate Therapeutics Slides: Corporate presentation

Jun 3, 2026, 7:00 AM EDT - 4 weeks ago

Fate Therapeutics Slides: Corporate presentation


Fate Therapeutics assumed with a Buy at Jefferies

2026-05-19T19:15:09.000Z - 6 weeks ago

Fate Therapeutics assumed with a Buy at Jefferies


Fate Therapeutics reports Q1 EPS (26c), consensus (28c)

2026-05-13T15:28:57.000Z - 7 weeks ago

Fate Therapeutics reports Q1 EPS (26c), consensus (28c)


Fate Therapeutics Earnings release: Q1 2026

May 13, 2026, 8:30 AM EDT - 7 weeks ago

Fate Therapeutics Earnings release: Q1 2026


Fate Therapeutics Quarterly report: Q1 2026

May 13, 2026, 8:30 AM EDT - 7 weeks ago

Fate Therapeutics Quarterly report: Q1 2026


Fate Therapeutics Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 2 months ago

Fate Therapeutics Proxy statement: Proxy filing


Fate Therapeutics Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 2 months ago

Fate Therapeutics Proxy statement: Proxy filing


Fate Therapeutics announces data presentation of FT839

2026-04-16T13:53:30.000Z - 2 months ago

Fate Therapeutics announces data presentation of FT839


Fate Therapeutics reports Q4 EPS (77c), consensus (27c)

2026-02-26T14:07:37.000Z - 4 months ago

Fate Therapeutics reports Q4 EPS (77c), consensus (27c)


Fate Therapeutics Earnings release: Q4 2025

Feb 26, 2026, 7:00 AM EST - 4 months ago

Fate Therapeutics Earnings release: Q4 2025


Fate Therapeutics Annual report: Q4 2025

Feb 26, 2026, 7:00 AM EST - 4 months ago

Fate Therapeutics Annual report: Q4 2025


Fate Therapeutics Annual report: Q4 2025

Feb 26, 2026, 7:00 AM EST - 4 months ago

Fate Therapeutics Annual report: Q4 2025


Fate Therapeutics Slides: Corporate presentation

Feb 26, 2026, 7:00 AM EST - 4 months ago

Fate Therapeutics Slides: Corporate presentation


Fate Therapeutics presents updated Phase 1 data of FT819

2025-12-08T13:21:05.000Z - 7 months ago

Fate Therapeutics presents updated Phase 1 data of FT819


Fate Therapeutics reports Q3 EPS (27c), consensus (28c)

2025-11-13T13:35:50.000Z - 8 months ago

Fate Therapeutics reports Q3 EPS (27c), consensus (28c)


Fate Therapeutics Earnings release: Q3 2025

Nov 13, 2025, 8:30 AM EST - 8 months ago

Fate Therapeutics Earnings release: Q3 2025


Fate Therapeutics Quarterly report: Q3 2025

Nov 13, 2025, 8:30 AM EST - 8 months ago

Fate Therapeutics Quarterly report: Q3 2025


Fate Therapeutics appoints Adawi as CFO

2025-10-14T12:15:56.000Z - 9 months ago

Fate Therapeutics appoints Adawi as CFO


Fate Therapeutics reports Q2 EPS (29c), consensus (34c)

2025-08-12T20:17:43.000Z - 11 months ago

Fate Therapeutics reports Q2 EPS (29c), consensus (34c)


Fate Therapeutics Earnings release: Q2 2025

Aug 12, 2025, 7:00 AM EDT - 11 months ago

Fate Therapeutics Earnings release: Q2 2025


Fate Therapeutics Quarterly report: Q2 2025

Aug 12, 2025, 7:00 AM EDT - 11 months ago

Fate Therapeutics Quarterly report: Q2 2025


Fate Therapeutics announces updated data for FT819

2025-06-11T13:10:38.000Z - 1 year ago

Fate Therapeutics announces updated data for FT819


Fate Therapeutics reports Q1 EPS (32c), consensus (38c)

2025-05-13T20:10:50.000Z - 1 year ago

Fate Therapeutics reports Q1 EPS (32c), consensus (38c)


Fate Therapeutics Quarterly report: Q1 2025

May 13, 2025, 4:00 PM EDT - 1 year ago

Fate Therapeutics Quarterly report: Q1 2025


Fate Therapeutics Earnings release: Q1 2025

May 13, 2025, 4:00 PM EDT - 1 year ago

Fate Therapeutics Earnings release: Q1 2025


Fate Therapeutics Proxy statement: Proxy Filing

Apr 17, 2025, 8:00 AM EDT - 1 year ago

Fate Therapeutics Proxy statement: Proxy Filing


Fate Therapeutics Proxy statement: Proxy Filing

Apr 17, 2025, 8:00 AM EDT - 1 year ago

Fate Therapeutics Proxy statement: Proxy Filing


Fate Therapeutics Proxy statement: Proxy Filing

Apr 7, 2025, 8:00 AM EDT - 1 year ago

Fate Therapeutics Proxy statement: Proxy Filing


Fate Therapeutics Annual report: Q4 2024

Mar 5, 2025, 4:00 PM EST - 1 year ago

Fate Therapeutics Annual report: Q4 2024


Fate Therapeutics Earnings release: Q4 2024

Mar 5, 2025, 4:00 PM EST - 1 year ago

Fate Therapeutics Earnings release: Q4 2024


Fate Therapeutics to Present at Upcoming Investor Conferences

Feb 14, 2025, 4:01 PM EST - 1 year ago

Fate Therapeutics to Present at Upcoming Investor Conferences


Fate Therapeutics Slides: Corporate Presentation

Feb 7, 2025, 7:00 AM EST - 1 year ago

Fate Therapeutics Slides: Corporate Presentation


Fate Therapeutics Announces Leadership Transition

Nov 29, 2024, 1:05 PM EST - 1 year ago

Fate Therapeutics Announces Leadership Transition


Fate Therapeutics Quarterly report: Q3 2024

Nov 12, 2024, 3:00 PM EST - 1 year ago

Fate Therapeutics Quarterly report: Q3 2024


Fate Therapeutics Earnings release: Q3 2024

Nov 12, 2024, 3:00 PM EST - 1 year ago

Fate Therapeutics Earnings release: Q3 2024


Fate Therapeutics Quarterly report: Q2 2024

Aug 13, 2024, 4:00 PM EDT - 2 years ago

Fate Therapeutics Quarterly report: Q2 2024


Fate Therapeutics Earnings release: Q2 2024

Aug 13, 2024, 4:00 PM EDT - 2 years ago

Fate Therapeutics Earnings release: Q2 2024


Fate Therapeutics Earnings Call Transcript: Q1 2024

May 9, 2024, 5:00 PM EDT - 2 years ago

Fate Therapeutics Earnings Call Transcript: Q1 2024


Fate Therapeutics Quarterly report: Q1 2024

May 9, 2024, 5:00 PM EDT - 2 years ago

Fate Therapeutics Quarterly report: Q1 2024


Fate Therapeutics Earnings release: Q1 2024

May 9, 2024, 5:00 PM EDT - 2 years ago

Fate Therapeutics Earnings release: Q1 2024


Fate Therapeutics Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Fate Therapeutics Proxy statement: Proxy Filing


Fate Therapeutics Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Fate Therapeutics Proxy statement: Proxy Filing


Fate Therapeutics Registration statement: Registration Filing

Apr 18, 2024, 8:00 AM EDT - 2 years ago

Fate Therapeutics Registration statement: Registration Filing


Fate Therapeutics Proxy statement: Proxy Filing

Apr 16, 2024, 8:00 AM EDT - 2 years ago

Fate Therapeutics Proxy statement: Proxy Filing


Fate Therapeutics Earnings Call Transcript: Q4 2023

Feb 26, 2024, 5:00 PM EST - 2 years ago

Fate Therapeutics Earnings Call Transcript: Q4 2023


Fate Therapeutics Annual report: Q4 2023

Feb 26, 2024, 5:00 PM EST - 2 years ago

Fate Therapeutics Annual report: Q4 2023


Fate Therapeutics Earnings release: Q4 2023

Feb 26, 2024, 5:00 PM EST - 2 years ago

Fate Therapeutics Earnings release: Q4 2023


Fate Therapeutics Slides: Corporate Presentation

Nov 9, 2023, 8:00 PM EST - 2 years ago

Fate Therapeutics Slides: Corporate Presentation


Fate Therapeutics Earnings Call Transcript: Q3 2023

Nov 8, 2023, 5:00 PM EST - 2 years ago

Fate Therapeutics Earnings Call Transcript: Q3 2023


Fate Therapeutics Quarterly report: Q3 2023

Nov 8, 2023, 5:00 PM EST - 2 years ago

Fate Therapeutics Quarterly report: Q3 2023


Fate Therapeutics Earnings release: Q3 2023

Nov 8, 2023, 5:00 PM EST - 2 years ago

Fate Therapeutics Earnings release: Q3 2023


Fate Therapeutics Registration statement: Registration Filing

Nov 8, 2023, 7:00 AM EST - 2 years ago

Fate Therapeutics Registration statement: Registration Filing


Fate Therapeutics Earnings Call Transcript: Q2 2023

Aug 8, 2023, 5:00 PM EDT - 3 years ago

Fate Therapeutics Earnings Call Transcript: Q2 2023


Fate Therapeutics Quarterly report: Q2 2023

Aug 8, 2023, 5:00 PM EDT - 3 years ago

Fate Therapeutics Quarterly report: Q2 2023


Fate Therapeutics Earnings release: Q2 2023

Aug 8, 2023, 5:00 PM EDT - 3 years ago

Fate Therapeutics Earnings release: Q2 2023


Rocketman808
Rocketman808 Jul. 3 at 2:33 AM
$FATE i sold my swing from 1.90 to 2.98 15k shares. Will reload if i have the chance, 285k core still here 😎
0 · Reply
MarketMaestro1
MarketMaestro1 Jul. 2 at 7:53 PM
This might be the fastest way to accumulate $1 million by the end of 2026: $DNA (Ginkgo Bioworks) → $8 Must buy $IONQ (IonQ) → $46 Must buy $EDIT (Editas Medicine) → $3.56 Must buy $FATE (Fate Therapeutics) → $3 Must buy $ADPT (Adaptive Biotechnologies) → $18 Must buy Next alert dropping soon! If you are not following us with notifications turned on, you might miss our next alerts. NFA
1 · Reply
philmori
philmori Jul. 2 at 6:50 PM
$FATE see some support... got in heavy.
0 · Reply
aquira
aquira Jul. 2 at 4:11 PM
$FATE whenever I post and brag here, this fooooken turd goes down. I'll just ignore this and wait for it to touch the 7 PT by end od year.
1 · Reply
gata2016
gata2016 Jul. 2 at 3:53 PM
$ICU We know pediatric treatment has already passed FDA. I would imagine there is a strong liklihood of adult population following suit. My low-end prediction for BO here is $125 at a modest $500M. At 1B, we are looking at a whopping $250/share. We arent far off my friends! $SLS $AUPH $FATE $CABA
2 · Reply
Merlintrader
Merlintrader Jul. 2 at 2:52 PM
$FATE Fate Therapeutics (Nasdaq: $FATE): Off-the-Shelf iPSC Cell Therapy, FT819 Lupus Data, and the Next Autoimmune CAR-T Test Updated jul 2 https://www.merlintrader.com/fate-therapeutics-stock-hub/
0 · Reply
StockDaddy68
StockDaddy68 Jul. 2 at 2:31 PM
$FATE This is what I'm buying with my profits!
1 · Reply
StockDaddy68
StockDaddy68 Jul. 2 at 2:29 PM
$FATE I just might go out and buy me a 1972 Cadillac Eldorado convertible!
1 · Reply
aquira
aquira Jul. 2 at 2:23 PM
$FATE my average of 1.365 is foooken happy
0 · Reply
gata2016
gata2016 Jul. 2 at 2:14 PM
$ICU Added about 100 more. Not a ton, but these are shares that arent going anywhere. Looking to lock the float on this one. $SLS $AUPH $FATE
0 · Reply
StockDaddy68
StockDaddy68 Jul. 2 at 2:07 PM
$FATE Good Morning Friends and HUBBA HUBBA!
1 · Reply
Jake140
Jake140 Jul. 2 at 2:02 PM
$FATE The volume...just look at the volume! And I still think we are flying below the radar. Just wait until more discover FATE!!! Breaking 52 week records daily now!
0 · Reply
Rocketman808
Rocketman808 Jul. 2 at 1:21 PM
$FATE good morning, reporting in, gravity is weak up here 👨🏼‍🚀🚀
1 · Reply
Jake140
Jake140 Jul. 2 at 9:19 AM
$FATE Morning All! Let's see what the day brings...
0 · Reply
Nik7777
Nik7777 Jul. 2 at 8:49 AM
$FATE Good morning everyone and have a good mood
0 · Reply
GangsterX
GangsterX Jul. 2 at 5:54 AM
$FATE $CMPX $CNTX $PEPG $PMVP Never sell baby
1 · Reply
youbi336
youbi336 Jul. 2 at 2:00 AM
$NKTX Come on! Even $FATE which has always lagged behind one whole dollar has caught up and overtook! Time to move!
0 · Reply
Nik7777
Nik7777 Jul. 2 at 1:41 AM
0 · Reply
EddieHayes
EddieHayes Jul. 1 at 10:40 PM
52-week breakout tape (07/01) $RAAQ +24% $RFL +15% $GH +14% $ADAG +14% $FATE +12% OSCR+12% BOF +11% CPIX +10% RAAQ leading the pack after IQM Quantum Computers completed its SPAC merger with Real Asset Acquisition Corp, officially listing on Nasdaq. Classic SPAC re-rating flow on a fresh public debut with quantum/AI adjacency narrative catching attention. What stands out here is not just the individual moves, but the breadth of small-cap momentum breaking out across sectors while large caps chop. This is how early risk appetite expansion usually starts, rotation shows up in names most people aren’t watching yet. To my subscribers and future subscribers: when the next bull run starts, this is the type of portfolio performance we are working to build again. The real question is simple: are you positioned early, or reacting late when everything is already moving? Are you going to miss out again?
0 · Reply
LewisDaKat
LewisDaKat Jul. 1 at 10:00 PM
$FATE Fate Therapeutics to Participate in Upcoming Third Quarter 2026 Conferences https://marketwirenews.com/stock/fate/news/fate-therapeutics-to-participate-in-upcoming-third-q-8028904155048688.html?utm_source=stocktwits
0 · Reply
Randy2979
Randy2979 Jul. 1 at 8:25 PM
$FATE https://ir.fatetherapeutics.com/news-releases/news-release-details/fate-therapeutics-participate-upcoming-third-quarter-2026
0 · Reply
MarketsParadise
MarketsParadise Jul. 1 at 8:15 PM
Small caps heating up, We are seeing some big runners lately. Take a look at ticker DRCT 💎 I believe this is the next monster runner waiting to be found: DRCT 💎 • 600K share float! • AI-powered digital advertising & marketing drive. • Extremely thin chart. • Any sustained buying pressure we look for the 5$+. $TC $NNBR $WCT.X $FATE .,1
0 · Reply